Chandler Robinson - Chief Executive Officer, Director at Monopar Therapeutics

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
MNPR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Chandler Robinson since 28 Sep 2025

Reported holdings for Chandler Robinson in Monopar Therapeutics

Form 4 holding Chief Executive Officer, Director

Monopar Therapeutics

Security class
Restricted Stock Units
Shares / value
121,732
Estimated value
$3,446,898
Report date
02 Dec 2025
Price
$36.41
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Monopar Therapeutics

Security class
Restricted Stock Unit
Shares / value
93,403
Estimated value
Report date
30 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Monopar Therapeutics

Security class
Stock Options
Shares / value
16,753
Estimated value
Report date
02 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Chandler Robinson in Monopar Therapeutics

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .